Skip to main content
Clinical Trials/ISRCTN13670619
ISRCTN13670619CompletedNot Applicable

A comparative study of the bactericidal and sterilising activity of three fluoroquinolones: gatifloxacin, moxifloxacin and ofloxacin substituted for ethambutol in the two month initial phase of the standard anti-tuberculosis treatment regimen also containing rifampicin, isoniazid and pyrazinamide (South Africa)

ICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR)0 sites0 target enrollmentStarted: June 7, 2005Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Male/female of 18-65 years
  • 2. Weight 38-80 kg
  • 3. Recently microscopically diagnosed pulmonary TB
  • 4. Findings in medical history and physical examination not exceeding grade 2
  • 5. Voluntarily signed informed consent
  • 6. Confirmed negative pregnancy test at the screening visit
  • 7. Willing to use effective contraceptive methods during treatment
  • 8. Normal lab values not exceeding grade 2, except haemoglobin <6.5 g/dl and potassium <3.0 mEq/l (>grade 1)
  • 9. Consent for a pre-screening biological test to exclude possible Multi Drug Resistant (MDR) TB and Negative MDR TB screen test will be a check if pre-screening biological test is done

Exclusion Criteria

  • 1. History of TB within the last 3 years
  • 2. Concomitant infection requiring additional anti-infectious treatment (especially anti-retroviral medication [ARV])
  • 3. Human immunodeficiency virus (HIV) infected patients at World Health Organisation (WHO) stage 4
  • 4. Diabetes mellitus or non insulin dependent diabetes mellitus requiring treatment
  • 5. Drug and alcohol abuse
  • 6. History of drug hypersensitivity and/or active allergic disease
  • 7. Impaired renal, hepatic or gastric function that may interfere with drug absorption, distribution, metabolism or elimination

Investigators

Sponsor
ICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR)

Similar Trials

A comparative study of the bactericidal... | Clinical Trial